Literature DB >> 26385567

Treatment and ovarian preservation in children with ovarian tumors.

Takaharu Oue1, Shuichiro Uehara2, Takashi Sasaki3, Satoko Nose3, Ryuta Saka3, Hiroaki Yamanaka2, Takehisa Ueno2, Yuko Tazuke2, Hiroomi Okuyama2.   

Abstract

BACKGROUND/
PURPOSE: Ovarian preservation is desirable in children with ovarian tumors. However, the diagnostic and treatment strategies are heterogeneous. The aim of this study was to investigate the management and preservation of ovarian tissue in order to identify the factors associated with ovarian preservation.
METHODS: Thirty-seven patients (41 ovaries) were surgically treated for ovarian tumors. Four cases were bilateral. The data on the patient symptoms at presentation, imaging, treatment, outcome, pathology, and status of ovarian preservation were retrospectively analyzed for each patient.
RESULTS: Histological examinations revealed 25 mature teratomas, 5 immature teratomas, 5 cystadenomas, 2 dysgerminomas, and other tumors. Ovarian torsion occurred in 16 ovaries (39%). Ovary-sparing surgery was performed in 22 ovaries (53.7%). Successful ovarian preservation was significantly associated with a smaller tumor size, benign pathology, and a lower degree of torsion (P<0.01).
CONCLUSIONS: Because the prognosis was favorable in most cases, the preservation of fertility and gonadal function should be a goal in the surgical treatment of ovarian tumors. We recommend ovary-sparing surgery as the first-line treatment for all pediatric ovarian tumors other than those that are preoperatively diagnosed as being malignant and those in which emergent surgical intervention is indicated owing to the suspicion of ovarian torsion.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ovarian preservation; Ovarian tumor; Ovary-sparing surgery; Pediatric; Torsion

Mesh:

Year:  2015        PMID: 26385567     DOI: 10.1016/j.jpedsurg.2015.08.036

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  7 in total

1.  The role of preoperative imaging and tumor markers in predicting malignant ovarian masses in children.

Authors:  Guogang Ye; Ting Xu; Jiangbin Liu; Weijue Xu; Zhibao Lv
Journal:  Pediatr Surg Int       Date:  2019-11-07       Impact factor: 1.827

2.  Post-resection outcomes for pediatric ovarian neoplasm: is ovarian-preserving surgery a good option?

Authors:  Nima Azarakhsh; Sandra Grimes; Pranit N Chotai; Claudette Shephard; Eunice Y Huang
Journal:  Pediatr Surg Int       Date:  2016-10-13       Impact factor: 1.827

3.  Long-term surgical outcomes in pediatric ovarian neoplasms: 20-year single-center experience.

Authors:  Bade Toker Kurtmen; Zafer Dokumcu; Emre Divarci; Orkan Ergun; Geylani Ozok; Ahmet Celik
Journal:  Pediatr Surg Int       Date:  2022-09-28       Impact factor: 2.003

Review 4.  Review of a 25-Year Experience in the Management of Ovarian Masses in Neonates, Children and Adolescents: From Laparoscopy to Robotics and Indocyanine Green Fluorescence Technology.

Authors:  Esposito Ciro; Coppola Vincenzo; Cerulo Mariapina; Del Conte Fulvia; Bagnara Vincenzo; Esposito Giorgia; Carulli Roberto; Benedetta Lepore; Marco Castagnetti; Gianluigi Califano; Maria Escolino
Journal:  Children (Basel)       Date:  2022-08-12

5.  Myxoma of the Ovary: in Regard to Bedir et al. (Balkan Med J 2018;35:120-121)

Authors:  Nicolas Sterkers; Francis Salvat; Philippe Sappa; Olivier Donnez
Journal:  Balkan Med J       Date:  2018-10-01       Impact factor: 2.021

6.  Evaluation of the usefulness of laparoscopy in the diagnosis and treatment of adnexal pathologies in the pediatric population.

Authors:  Aleksandra Raźnikiewicz; Wojciech Korlacki; Andrzej Grabowski
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-03-28       Impact factor: 1.195

7.  Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors.

Authors:  Fuxia Xiao; Lin Zhang; Sihua Yang; Kun Peng; Ting Hua; Guangyu Tang
Journal:  J Ovarian Res       Date:  2022-01-22       Impact factor: 4.234

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.